Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Bioniche Life Sciences Inc T.BNC

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s): BNHLF

Bioniche Life Sciences Inc is a Research-based, technology-driven biopharmaceutical company involved in the discovery, development, manufacturing and marketing of proprietary products for human and animal health markets.
Price: $0.22 | Change: $0.00 | % Change: 0.00%
Volume: 45,689 | Day High/Low: 0.22/0.215 | 52 Week High/Low: 0.415/0.18

View modes: 
0 stars

Bioniche = Animal Health

My guess is that a name change will be  closer to our business of Human Health. We also want to move away from animal health. If Bioniche did a rights offering would you take up your pro rata share...read more
0 stars

RE:Let's Keep A Positive Attitude

I agree with SWNE. The new CEO is putting the house in order in anticipation of better days ahead. There have been hints of a merger or partnership, probably the reason for a name change. Why did...read more
0 stars

RE:Heading to a dime

The empties in your garage are worth 200 mil.  Thats a lot of drinking.  You must have been in this a long time.  rate and reply
0 stars

Heading to a dime

before the next financing. And I thought that the previous regime was oblivious to the concept of building value for shareholders? Apparently the CEO is working on some measures for  improving...read more
0 stars

.15 cents anyone?

They abolished the penny,  why don't they do the same with penny stocks?  rate and reply
0 stars

RE:RE:RE:RE:Where are we now?

Tson99, here is something to keep in mind - if not now but later you will finally understand that it hurts financially if you put rose glasses and let yourself be too optimistic. Trial did fail.  As a...read more
0 stars

Let's Keep A Positive Attitude

Our new CEO is cracking the whip and making things happen. We may now be able to sit back and watch this Company blossom.  (-:  rate and reply
0 stars

Q3 and Q4 earnings

RB We had AH sales in Q3 and sold the business in Q4 so there will be sales in both quarters. In Q4 there will also be rent to report from the purchaser of AH Now Q1 2015 will be easier I agree. HT  rate and reply
1 star

RE:RE:RE:Where are we now?

The trial didn't fail, it was aborted because it would have never finished due to the fact that they could not get patients to participate. The Endo phase IIIb trial proved nothing about Urocidin...read more
0 stars

RE:It is a done deal

will that be before or after further share dilution .........  rate and reply
0 stars

RE:RE:Where are we now?

UROCIDIN and soiled toilet paper....  hmmm this kind of comparison never came to my mind... hmmm. Interesting.  After failed PIIIb trial and waste of ~$100 million sure it must hurt.  Sad story.  rate and reply
0 stars

RE:Where are we now?

I do believe that after the urocidin fiasco with endo that their ceo or president got the pink slip.  They got some of their urocidin rights back through buying Paladin.  Their shareholders must feel...read more
0 stars

OUR BUSINESS: ANIMALS. OUR ADVANTAGE: PEOPLE

lol...last line in todays NR.....some sense of humour these guys have eh? looks like the market is REALLY embracing the outcome of the vote. NOT!  rate and reply
0 stars

RE:It is a done deal

Earnings should be pretty easy to figure out....lol  rate and reply
0 stars

It is a done deal

Press release at 9:00 confirming the sale took place. so see you guys in May after Q3 earnings comes out. HT  rate and reply
1 star

RE:Look at the volume!!!!

Raging BS, Are you surprised? No one cares about Bioniche any more. 60% of shares couldn't be bothered to vote for or against the liquidation of their entire revenue stream. management should find...read more
0 stars

Look at the volume!!!!

Awesome!   Big spenders here, I tell ya.   Deep pockets.   The whole nine yards.....  rate and reply
0 stars

RE:RE:Anyone care to take a shot....

Don't even go there!  rate and reply
0 stars

Where are we now?

complications are removed and things became quite clear - it's ONE trick pony now. 100%  reliance in the bet on Urocidin.   0%      ability to make money and produce something anything of value now. ...read more
0 stars

40% and Graeme McRea

have really hard time to get around this number....   40%.... when company changed itself completely....   What an embarassment.... Congratulations Mr.McRae, I guess it's reasonable to say that you...read more